<DOC>
	<DOCNO>NCT00638040</DOCNO>
	<brief_summary>The purpose study analyze gene expression pattern associate various microenvironmental stress tumor understand role tumor progression treatment response . To achieve goal , perform gene expression analysis tumor sample collect IRB-approved study ( IRB # : 4516-05-2R2 ) International Phase III Study Chemoradiotherapy versus Chemoradiotherapy Plus Hyperthermia Locally Advanced Cervical Cancer direct Dr. Mark Dewhirst . We correlate gene expression signatures different microenvironmental stress measure physiological parameter understand role tumor progression , treatment response clinical outcome .</brief_summary>
	<brief_title>The Gene Expression Studies Role Tumor Microenvironments Tumor Progression</brief_title>
	<detailed_description>In first part proposal , determine cellular response various microenvironmental factor ( lactosis , acidosis , hypoxia , glucose deprivation ) culture epithelial cell ( commercially obtain ) make use DNA microarray analysis . From analysis microarray assay , obtain gene signature reflect cell respond environment stress . These gene signature use analyze annotate gene expression pattern tumor sample whether hyperthermia affect physiological parameter correspond gene signature . In second part proposal , work Dr. Dewhirst perform gene expression study cervical cancer sample phase III , multicenter , randomize clinical trial ( IRB 4516-05-2R2 ) . The subject de-identified obtain directly PHI subject trial . Subjects randomize chemoradiotherapy alone chemoradiotherapy + hyperthermia . For subject randomize hyperthermia , heat treatment administer concurrently chemotherapy weekly course external beam radiation . In hyperthermia suite , catheter place cervical o , vagina rectum internal temperature monitoring . Hyperthermia give externally pelvis abdomen use BSD Sigma 60 , Sigma Eye Sigma Ellipse system . Initial power limit less 1500 watt phase amplitude adjust equal surface electric field quadrant applicator . Heating continue 60 minute average cervical o interstitial temperature 40째C achieve , maximum total duration 90 minute , whichever long . The bolus temperature 37째 initiation power reduce necessary patient comfort and/or help maintain oral temperature 38.5C . Power also reduce treatment stop patient request , due intractable pain , nausea vomiting , normal tissue temperature rise 44째C , pulse &gt; 160 , BP &gt; 180/100 &lt; 90/50 , alter mental status , systemic temperature &gt; 38.5째C . A . The research material include tumor biopsy obtain HT treatment use gene expression study well IHC ISH study finding microarray analysis . We also obtain information tumor physiological parameter information measure tumor . B . The data tumor physiological parameter measure response treatment clinical outcome patient also acquire . C. Only physicians take care patient access patient identifies Protected Health Information ( PHI ) . All information de-identified remain anonymous study . D. The specimen collect patient undergo medical care respective disease . No new material data need collect specifically proposal . These biopsy physiological measurement include original propose clinical trial .</detailed_description>
	<mesh_term>Anoxia</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Acidosis , Lactic</mesh_term>
	<criteria>Invasive cervical carcinoma ( small cell histology exclude ) Age 18 FIGO stage IIbIVa ECOG/WHO 0,1 , 2 , &gt; /= 70 % respectively WBC &gt; /= 3,000 , platelet &gt; /= 100,000 Hgb &gt; 12.0 g/dL &gt; 7.5 mmol/L , transfusion need Serum bilirubin &lt; /= 1.5 time ULN , transaminase &lt; /= 3 time ULN Calculated creatinine clearance &gt; 60 ml/liter ( Cockcroft ) Paraaortic adenopathy absent 1.5 cm great dimension CT/MRI No history myocardial infarction last 6 month No symptomatic angina pectoris Any past history coronary artery disease must require assessment clearance PCP and/or cardiologist Negative pregnancy test patient 50 Written informed consent Patients undergone surgical resection primary tumor eligible ( Limited surgical resection pelvic node without TAH acceptable ) Patients pacemaker implant defibrillator Patients significant metallic foreign body ( i.e . hip replacement , bone metallic rod , orthopedic plate , etc . ) Prior radiotherapy chemotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>hypoxia</keyword>
	<keyword>lactate</keyword>
	<keyword>pH</keyword>
	<keyword>tumor microenvironments</keyword>
	<keyword>survival</keyword>
</DOC>